ZA801821B - Improved anti-inflammatory combination having reduced ulcerogenicity - Google Patents

Improved anti-inflammatory combination having reduced ulcerogenicity

Info

Publication number
ZA801821B
ZA801821B ZA00801821A ZA801821A ZA801821B ZA 801821 B ZA801821 B ZA 801821B ZA 00801821 A ZA00801821 A ZA 00801821A ZA 801821 A ZA801821 A ZA 801821A ZA 801821 B ZA801821 B ZA 801821B
Authority
ZA
South Africa
Prior art keywords
improved anti
inflammatory combination
ulcerogenicity
reduced
reduced ulcerogenicity
Prior art date
Application number
ZA00801821A
Other languages
English (en)
Inventor
Tsung Ying Shen
Ying Shen Tsung
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA801821B publication Critical patent/ZA801821B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
ZA00801821A 1979-03-28 1980-03-27 Improved anti-inflammatory combination having reduced ulcerogenicity ZA801821B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/024,639 US4228161A (en) 1979-03-28 1979-03-28 Anti-inflammatory combination having reduced ulcerogenicity

Publications (1)

Publication Number Publication Date
ZA801821B true ZA801821B (en) 1981-11-25

Family

ID=21821627

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00801821A ZA801821B (en) 1979-03-28 1980-03-27 Improved anti-inflammatory combination having reduced ulcerogenicity

Country Status (13)

Country Link
US (1) US4228161A (fr)
EP (1) EP0017169B1 (fr)
JP (1) JPS55130915A (fr)
AR (1) AR230953A1 (fr)
AT (1) ATE2718T1 (fr)
AU (1) AU531174B2 (fr)
CA (1) CA1124648A (fr)
DE (1) DE3062251D1 (fr)
FI (1) FI800921A (fr)
IE (1) IE49652B1 (fr)
NZ (1) NZ193239A (fr)
PT (1) PT71015B (fr)
ZA (1) ZA801821B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
WO1983001382A1 (fr) * 1981-10-13 1983-04-28 Mroszczak, Edward Promedicaments de thioesters menageant le systeme gastrointestinal
ATE22879T1 (de) * 1982-04-27 1986-11-15 Noristan Ltd Pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
GB8607662D0 (en) * 1986-03-27 1986-04-30 Rainsford K D Pharmaceutical formulation
GB2201591B (en) * 1987-03-02 1990-11-14 Ricerfarma Srl Analgesic antipyretic and anti-inflammatory compositions.
US6767899B1 (en) 2000-08-29 2004-07-27 Leiner Health Services Corp. Composition and method for treatment of conditions having an inflammatory component

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3161564A (en) * 1960-10-03 1964-12-15 Salsbury S Lab Dr Veterinary composition containing halo-nitro-benzamides and methods of using same
US3674870A (en) * 1970-06-09 1972-07-04 Merck & Co Inc Phenyl benzoic acid compounds in compositions and methods for treating inflammation
US3714226A (en) * 1970-06-09 1973-01-30 Merck & Co Inc Phenyl benzoic acid compounds
HU170329B (fr) 1974-12-12 1977-05-28
US4016268A (en) * 1975-10-06 1977-04-05 Morton-Norwich Products, Inc. Method of combatting gastric ulceration
GB1509979A (en) * 1975-11-28 1978-05-10 Fisons Ltd Pharmaceutical compositions containing aspirin or indomethacin

Also Published As

Publication number Publication date
AU531174B2 (en) 1983-08-11
FI800921A (fi) 1980-09-29
AU5653780A (en) 1980-10-02
AR230953A1 (es) 1984-08-31
NZ193239A (en) 1984-07-31
JPH0153247B2 (fr) 1989-11-13
IE800633L (en) 1980-09-28
CA1124648A (fr) 1982-06-01
ATE2718T1 (de) 1983-03-15
EP0017169B1 (fr) 1983-03-09
PT71015B (en) 1981-06-25
IE49652B1 (en) 1985-11-13
PT71015A (en) 1980-04-01
US4228161A (en) 1980-10-14
JPS55130915A (en) 1980-10-11
EP0017169A1 (fr) 1980-10-15
DE3062251D1 (en) 1983-04-14

Similar Documents

Publication Publication Date Title
AU2489984A (en) Arylsulphonyls
GB2057439B (en) Quinazolinones
AU5569780A (en) Converters
JPS5664519A (en) Voltageefrequency converter
JPS5654628A (en) Magneticcelectric converter
AU530840B2 (en) Combine
GB2052900B (en) Frequency-to-binary converter
JPS5650479A (en) Hyphenncode converter
JPS5622572A (en) Converter
JPS55149861A (en) Voltageecurrent converter
JPS56101374A (en) Dccdc converter
DE3062251D1 (en) Improved anti-inflammatory combinations having reduced ulcerogenicity
JPS5622581A (en) Converter
JPS5696522A (en) Digitalltooanalog converter
JPS55141980A (en) Converter
AU4841379A (en) Z-aza-ergolines
JPS5640326A (en) Analoggdigital converter
JPS5678883A (en) Characterrsize converter
JPS55126213A (en) Magnentoooptical converter
HU179098B (en) Wire-stretcher
GB2041669B (en) Dc-ac-dc converter
JPS5598183A (en) 11substitutedd3*44epoxypyrrolidine
AU6334580A (en) **
JPS55119798A (en) Synchroodigital converter
JPS5643796A (en) Forming viaahole